Synthesis and <i>C</i>-Alkylation of Hindered Aldehyde Enamines
作者:David M. Hodgson、Christopher D. Bray、Nicholas D. Kindon、Nigel J. Reynolds、Steven J. Coote、Joann M. Um、K. N. Houk
DOI:10.1021/jo802016t
日期:2009.2.6
hindered lithium amides with terminal epoxides is described whereby aldehydeenamines are produced via a previously unrecognized reaction pathway. Some of these aldehydeenamines display unprecedented C-alkylation reactivity toward unactivated primary and secondary alkyl halides. For comparison, the reactivity of aldehydeenamines synthesized via a traditional condensation method was examined. C- rather
Process for making hydroisoindoline tachykinin receptor antagonists
申请人:Kuethe T. Jeffrey
公开号:US20070015923A1
公开(公告)日:2007-01-18
The present invention is directed to a process for preparing certain hydroisoindoline compounds which are useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance P. The compounds are useful in the treatment of certain disorders, including emesis, urinary incontinence, depression, and anxiety.
The present invention relates to viral polymerase inhibitors of formula (I) or salts, N-oxides, solvates, hydrates, racemates, enantiomers or isomers thereof, processes for their preparation and their use in the treatment of Flaviviridae viral infections such as Hepatitis C virus (HCV) infections.
The present invention relates to viral polymerase inhibitors of formula (I) or salts, N-oxides, solvates, hydrates, racemates, enantiomers or isomers thereof, processes for their preparation and their use in the treatment of Flaviviridae viral infections such as Hepatitis C virus (HCV) infections.